SCHEMBL23016293

SCHEMBL23016293

c1cc(-c2ccc3cc(-c4ccc5nc(-c6ccc(-c7ccc8ccc9cccnc9c8n7)c7ccccc67)ccc5c4)ccc3n2)c2cnccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 3/20 0.44
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
POLB P06746 2/20 0.40
MAPK10 P53779 3/20 0.39
CYP11B1 P15538 2/20 0.39
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B2 P19099 1/20 0.39
LMNA P02545 1/20 0.38
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 3/20 0.37
CYP2A6 P11509 1/20 0.37
CYP3A4 P08684 1/20 0.36
HTR2C P28335 1/20 0.36
PIK3CA P42336 1/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24475371 0.97 TNF (0.41) TNFRAB9ANPC1POLBMAPK10
SCHEMBL23016130 0.95 TNF (0.41) TNFRAB9ANPC1POLBMAPK10
SCHEMBL23016133 0.94 TNF (0.42) TNFRAB9ANPC1POLBMAPK10
SCHEMBL23016129 0.94 TNF (0.41) TNFRAB9ANPC1POLBMAPK10
SCHEMBL24475569 0.92 TNF (0.45) TNFRAB9ANPC1POLBMAPK10
SCHEMBL24475517 0.92 TNF (0.39) TNFRAB9ANPC1POLBMAPK10
SCHEMBL22282120 0.92 TNF (0.40) TNFRAB9ANPC1POLBMAPK10
SCHEMBL23016163 0.91 IKBKE (0.43) RAB9ANPC1POLBCYP11B1CYP17A1
SCHEMBL23016097 0.91 NPC1 (0.45) RAB9ANPC1POLBLMNAKDM4E
SCHEMBL24475592 0.91 TNF (0.39) TNFRAB9ANPC1POLBMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10930857-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2021-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10930857-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA TNF 1871/4885RAB9A 3913/4885NPC1 4299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.